Globeimmune (GBIM) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartShort InterestBuy This Stock Globeimmune Short Interest DataGlobeimmune (GBIM) has a short interest of 8,400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 410 shares to cover all short positions.Current Short Interest8,400 sharesPrevious Short Interest8,400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.68Short Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2025Today's Trading Volume0 sharesAverage Trading Volume410 sharesToday's Volume Vs. Average0% Short Selling Globeimmune? Sign up to receive the latest short interest report for Globeimmune and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGBIM Short Interest Over TimeGBIM Days to Cover Over TimeGBIM Percentage of Float Shorted Over Time Globeimmune Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20258,400 shares $1.68 No ChangeN/A0 $0.00 5/31/20258,400 shares $1.68 No ChangeN/A84 $0.00 5/15/20258,400 shares $1.68 No ChangeN/A0 $0.00 4/30/20258,400 shares $1.68 No ChangeN/A0 $0.00 4/15/20258,400 shares $1.68 No ChangeN/A0 $0.00 3/31/20258,400 shares $1.68 No ChangeN/A0 $0.00 3/15/20258,400 shares $1.68 No ChangeN/A0 $0.00 2/28/20258,400 shares $1.68 No ChangeN/A2.8 $0.00 2/15/20258,400 shares $0.00 No ChangeN/A0 $0.00 1/31/20258,400 shares $0.00 No ChangeN/A0 $0.00 Get the Latest News and Ratings for GBIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Globeimmune and its competitors with MarketBeat's FREE daily newsletter. 1/15/20258,400 shares $0.00 No ChangeN/A12 $0.00 12/31/20248,400 shares $0.00 No ChangeN/A0 $0.00 12/15/20248,400 shares $0.00 No ChangeN/A84 $0.00 11/30/20248,400 shares $0.00 No ChangeN/A0 $0.00 11/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 10/31/20248,400 shares $0.00 No ChangeN/A0 $0.00 10/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 9/30/20248,400 shares $0.00 No ChangeN/A21 $0.00 9/15/20248,400 shares $0.00 No ChangeN/A84 $0.00 8/31/20248,400 shares $0.00 No ChangeN/A84 $0.00 8/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 7/31/20248,400 shares $0.00 No ChangeN/A0 $0.00 7/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 6/30/20248,400 shares $0.00 No ChangeN/A0 $0.00 6/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 5/31/20248,400 shares $0.00 No ChangeN/A0 $0.00 5/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 4/30/20248,400 shares $0.00 No ChangeN/A0 $0.00 4/15/20248,400 shares $0.00 No ChangeN/A0 $0.00 3/31/20248,400 shares $0.00 No ChangeN/A0 $0.00 3/15/20248,400 shares $0.00 No ChangeN/A10.5 $0.00 2/29/20248,400 shares $0.00 No ChangeN/A5.6 $0.00 2/15/20248,400 shares $0.00 No ChangeN/A10.5 $0.00 1/15/20248,400 shares $1.68 No ChangeN/A0 $0.00 12/31/20238,400 shares $1.68 No ChangeN/A0 $0.00 12/15/20238,400 shares $1.68 No ChangeN/A0 $0.00 11/30/20238,400 shares $1.68 No ChangeN/A0 $0.00 11/15/20238,400 shares $1.68 No ChangeN/A84 $0.00 10/31/20238,400 shares $1.68 No ChangeN/A0 $0.00 10/15/20238,400 shares $1.68 No ChangeN/A1.5 $0.00I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare. 9/30/20238,400 shares $1.68 No ChangeN/A0 $0.00 9/15/20238,400 shares $1.68 No ChangeN/A84 $0.00 8/31/20238,400 shares $1.68 No ChangeN/A20.9 $0.00 8/15/20238,400 shares $1.68 No ChangeN/A0 $0.00 7/31/20238,400 shares $1.68 No ChangeN/A1.4 $0.00 7/15/20238,400 shares $2.52 No ChangeN/A10.5 $0.00 6/30/20238,400 shares $1.68 No ChangeN/A0 $0.00 6/15/20238,400 shares $1.68 No ChangeN/A84 $0.00 5/31/20238,400 shares $5.88 No ChangeN/A84 $0.00 5/15/20238,400 shares $5.88 No ChangeN/A9.3 $0.00 4/30/20238,400 shares $6.72 No ChangeN/A0 $0.00 4/15/20238,400 shares $6.72 No ChangeN/A84 $0.00 3/31/20238,400 shares $6.72 No ChangeN/A84 $0.00 3/15/20238,400 shares $6.72 No ChangeN/A28 $0.00 2/28/20238,400 shares $5.88 No ChangeN/A16.8 $0.00 2/15/20238,400 shares $5.88 No ChangeN/A84 $0.00 1/31/20238,400 shares $5.88 No ChangeN/A14 $0.00 1/15/20238,400 shares $5.88 No ChangeN/A28 $0.00 12/30/20228,400 shares $5.88 No ChangeN/A4.9 $0.00 12/15/20228,400 shares $5.88 No ChangeN/A5.3 $0.00 11/30/20228,400 shares $5.88 No ChangeN/A42 $0.00 11/15/20228,400 shares $5.88 No ChangeN/A84 $0.00 10/31/20228,400 shares $5.88 No ChangeN/A0 $0.00 10/15/20228,400 shares $5.88 No ChangeN/A84 $0.00 9/30/20228,400 shares $5.88 No ChangeN/A16.8 $0.00 9/15/20228,400 shares $5.88 No ChangeN/A84 $0.00 8/31/20228,400 shares $5.88 No ChangeN/A84 $0.00 8/15/20228,400 shares $5.88 No ChangeN/A42 $0.00 7/31/20228,400 shares $5.88 No ChangeN/A16.8 $0.00 7/15/20228,400 shares $5.88 No ChangeN/A28 $0.00 6/30/20228,400 shares $5.04 No ChangeN/A7 $0.00 6/15/20228,400 shares $4.20 No ChangeN/A84 $0.00 5/31/20228,400 shares $4.20 No ChangeN/A84 $0.00 5/15/20228,400 shares $4.20 No ChangeN/A0 $0.00 4/30/20228,400 shares $4.20 No ChangeN/A84 $0.00 4/15/20228,400 shares $4.20 No ChangeN/A28 $0.00 3/31/20228,400 shares $4.20 No ChangeN/A0 $0.00 3/15/20228,400 shares $4.20 No ChangeN/A7.6 $0.00 2/28/20228,400 shares $420.00 No ChangeN/A0 $0.05 2/15/20228,400 shares $420.00 No ChangeN/A4.2 $0.05 1/31/20228,400 shares $420.00 No ChangeN/A84 $0.05 1/15/20228,400 shares $0.00 No ChangeN/A84 $0.00 12/31/20218,400 shares $0.84 No ChangeN/A0.4 $0.00 12/15/20218,400 shares $0.00 No ChangeN/A42 $0.00 11/30/20218,400 shares $101.56 No ChangeN/A84 $0.01 11/15/20218,400 shares $101.64 No ChangeN/A4.4 $0.01 10/29/20218,400 shares $2.94 thousand No ChangeN/A0 $0.35 10/15/20218,400 shares $2.94 thousand No ChangeN/A0 $0.35 9/30/20218,400 shares $2.94 thousand No ChangeN/A4.2 $0.35 9/15/20218,400 shares $1.93 thousand -4.6%N/A0.7 $0.23I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare. 8/31/20218,800 shares $3.14 thousand -13.7%N/A0.3 $0.36 8/13/202110,200 shares $5.09 thousand -1.9%N/A0.4 $0.50 7/30/202110,400 shares $5.30 thousand +23.8%N/A0.4 $0.51 7/15/20218,400 shares $4.87 thousand -1.2%N/A0.2 $0.58 6/30/20218,500 shares $8.67 thousand No ChangeN/A0.1 $1.02 6/15/20218,500 shares $10.63 thousand -8.6%N/A0.7 $1.25 5/28/20219,300 shares $12.65 thousand -1.1%N/A0.6 $1.36 5/14/20219,400 shares $9.87 thousand -4.1%N/A0.9 $1.05 4/30/20219,800 shares $13.03 thousand -13.3%N/A1.1 $1.33 4/15/202111,300 shares $17.23 thousand -43.8%N/A0.4 $1.53 3/31/202120,100 shares $38.19 thousand -7.8%N/A0.4 $1.90 3/15/202121,800 shares $52.32 thousand +10.7%N/A0.5 $2.40 2/26/202119,700 shares $78.01 thousand +80.7%N/A0.1 $3.96 2/12/202110,900 shares $14.72 thousand +26.7%N/A0.1 $1.35 1/29/20218,600 shares $3.01 thousand -11.3%N/A0.1 $0.35 1/15/20218,500 shares $2.30 thousand No ChangeN/A0.1 $0.27 12/31/202017,400 shares $5.05 thousand +104.7%N/A0.1 $0.29 12/15/20208,500 shares $1.28 thousand No ChangeN/A0.1 $0.15 11/30/20208,500 shares $1.07 thousand -32.0%N/A2.6 $0.13 11/15/202012,500 shares $2.13 thousand +14.7%N/A6.6 $0.17 10/30/202010,900 shares $1.83 thousand -31.5%N/A2.1 $0.17 10/15/202015,900 shares $2.66 thousand +16.9%N/A0.9 $0.17 9/30/202013,600 shares $2.04 thousand +61.9%N/A0.2 $0.15 9/15/20208,400 shares $1.46 thousand No ChangeN/A0.2 $0.17 8/31/20208,400 shares $2.52 thousand No ChangeN/A6 $0.30 8/14/20208,400 shares $3.36 thousand No ChangeN/A0.7 $0.40 7/31/20208,400 shares $3.15 thousand -2.3%N/A0.6 $0.38 7/15/20208,600 shares $3.25 thousand -67.3%N/A0 $0.38 GBIM Short Interest - Frequently Asked Questions What is Globeimmune's current short interest? Short interest is the volume of Globeimmune shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 8,400 shares of GBIM short. Learn More on Globeimmune's current short interest. How does Globeimmune's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Globeimmune: Ampio Pharmaceuticals, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Globeimmune stock? Short selling GBIM is an investing strategy that aims to generate trading profit from Globeimmune as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Globeimmune? A short squeeze for Globeimmune occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GBIM, which in turn drives the price of the stock up even further. How often is Globeimmune's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GBIM, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies 4Front Ventures Short Interest Algernon Pharmaceuticals Short Interest Allstar Health Brands Short Interest Alvotech Short Interest American Bio Medica Short Interest Ampio Pharmaceuticals Short Interest Anthera Pharmaceuticals Short Interest AstraZeneca Short Interest AVVAA World Health Care Products Short Interest AXIM Biotechnologies Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GBIM) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globeimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globeimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GBIM Stock Alerts